Clinical Trial Update: Study To Evaluate GSK256066 In Subjects With Mild Bronchial Asthma [Phase 2]

View source ↗

Summary

Phase 2 study evaluating GSK256066 in subjects with mild asthma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• GSK256066

Snippet

Sponsor: GlaxoSmithKline | Conditions: Asthma, Mild Asthma | Phase 2 | Status: COMPLETED